🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +21.72% on $IMNM in just 19h 36m.
VCY
$VCYT
🔒 US EquitiesVeracyte, Inc.
AVG HISTORICAL GAP
+4.60%
MAX GAP RECORD
+20.07%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $VCYT
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$VCYT
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 04, 2026 Earnings Release 2026-11-04 (AFTER CLOSE (21:00)) |
+0.00%
|
| Jul 30, 2026 Earnings Release 2026-07-30 (AFTER CLOSE) |
-18.42%
|
| May 05, 2026 Earnings Release 2026-05-05 (AFTER CLOSE) |
+18.29%
|
| Feb 25, 2026 Earnings Release 2026-02-25 (AFTER CLOSE) |
+7.81%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (AFTER CLOSE) |
+10.74%
|
| Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE) |
+8.47%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
-2.11%
|
| Feb 24, 2025 Earnings Release 2025-02-24 (AFTER CLOSE) |
-8.28%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
8.7%
Bullish Gaps (11)
Bearish Gaps (4)
Neutral / Flat (0)
📖 Intelligence Summary
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗